GENERAL INFORMATION
 

Project title
 

Scientific Response against COVID

Priority area
 

Universities, public and private R&D institutes / centers, SMEs and large-scale companies; Other stakeholders in the R&D ecosystem in the field of vaccine and drug development; Researchers working in the field of vaccine and drug development within the scope of combating COVID-19 under the mentioned institutions

Beneficiary

Scientific and Technological Research Council of Turkey (TUBITAK)

Co-Beneficiary
 

Turkish Health Institutes Presidency (TÜSEB)

Duration

30 months, 09.07.2021

EU contribution (Euro)

8.000.000

PROJECT SUMMARY

Brief description of the project and main objectives
 

With the project, it is aimed to support research and development activities for vaccine and drug development within the framework of a platform where universities, public and private R&D organizations and private sector organizations work in cooperation within the scope of combating the COVID-19 epidemic.

Location

Ankara, Kocaeli

Achievements / expected outputs

• Providing financial support to the pre-clinical and clinical stages of vaccine and drug development projects under the COVID-19 Turkey Platform
• Conducting the preclinical stages under the coordination of TÜBİTAK and clinical stages under the coordination of TÜSEB